We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$38.7B
AUM Growth
+$5.1B
(+15%)
Cap. Flow
+$551M
Cap. Flow
% of AUM
1.42%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
1,486
New
101
Increased
869
Reduced
411
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$130M |
| 2 |
Franco-Nevada
FNV
|
+$128M |
| 3 |
B
Barrick Mining
B
|
+$98.9M |
| 4 |
Dominion Energy
D
|
+$96M |
| 5 |
Monolithic Power Systems
MPWR
|
+$88.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$133M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$104M |
| 3 |
SLB Ltd
SLB
|
+$90.4M |
| 4 |
Blackrock
BLK
|
+$89.1M |
| 5 |
Honeywell
HON
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 35.79% |
| 2 | Technology | 25.85% |
| 3 | Energy | 9% |
| 4 | Healthcare | 6.56% |
| 5 | Financials | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Enbridge
ENB
$118B
| $18.8M | 0.05% |
481,003
+59,540
| +14% | +$2.33M |
|
252
argenx
ARGX
$52B
| $18.7M | 0.05% |
49,482
-235
| -0.5% | -$87.9K |
|
|
SGEN
253
DELISTED
Seagen Inc. Common Stock
SGEN
| $18.4M | 0.05% |
143,156
+44,136
| +45% | +$5.7M |
|
|
BSX.PRA
254
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $18.2M | 0.05% |
158,737
+1,613
| +1% | +$178K |
|
255
Goldman Sachs BDC
GSBD
$993M
| $18M | 0.05% |
1,313,471
+43,859
| +3% | +$659K |
|
256
Jazz Pharmaceuticals
JAZZ
$15.8B
| $17.7M | 0.05% |
111,023
+15,825
| +17% | +$2.32M |
|
257
VICI Properties
VICI
$29.2B
| $17.7M | 0.05% |
545,472
+95,253
| +21% | +$3.06M |
|
258
iShares Global Infrastructure ETF
IGF
$10.9B
| $17.2M | 0.04% |
375,725
-15,667
| -4% | -$705K |
|
259
Incyte
INCY
$24B
| $17.2M | 0.04% |
214,415
+43,245
| +25% | +$3.31M |
|
|
AESC
260
DELISTED
The AES Corporation
AESC
| $16.8M | 0.04% |
164,543
+1,672
| +1% | +$164K |
|
261
IBM
IBM
$213B
| $16.6M | 0.04% |
117,646
+37,731
| +47% | +$5.2M |
|
262
Canadian National Railway
CNI
$76.1B
| $16.6M | 0.04% |
139,540
+9,150
| +7% | +$1.09M |
|
263
Estee Lauder
EL
$30.6B
| $16.4M | 0.04% |
66,206
+22,195
| +50% | +$4.96M |
|
264
VanEck CLO ETF
CLOI
$1.5B
| $16.2M | 0.04% |
320,000
+120,000
| +60% | +$6.02M |
|
265
Mondelez International
MDLZ
$78.8B
| $16.1M | 0.04% |
241,016
-20,795
| -8% | -$1.31M |
|
266
Target
TGT
$67.8B
| $16.1M | 0.04% |
107,741
-9,354
| -8% | -$1.47M |
|
267
Oaktree Specialty Lending
OCSL
$1.05B
| $15.9M | 0.04% |
772,819
+101,880
| +15% | +$2.05M |
|
268
Oil States International
OIS
$497M
| $15.9M | 0.04% |
2,133,219
+178,394
| +9% | +$1.1M |
|
269
Bio-Techne
TECH
$11.2B
| $15.6M | 0.04% |
188,807
+39,531
| +26% | +$3.14M |
|
270
VanEck Commodity Strategy ETF
PIT
$306M
| $15.5M | 0.04% |
+303,478
| New | +$15.3M |
|
271
Lowe's Companies
LOW
$119B
| $15.5M | 0.04% |
77,928
-4,427
| -5% | -$885K |
|
272
New Mountain Finance
NMFC
$683M
| $15.4M | 0.04% |
1,248,898
+103,464
| +9% | +$1.27M |
|
273
Stem
STEM
$50.3M
| $15.3M | 0.04% |
85,826
+26,190
| +44% | +$6.29M |
|
274
Bloom Energy
BE
$64.3B
| $15.1M | 0.04% |
792,092
+159,162
| +25% | +$3.13M |
|
275
Plug Power
PLUG
$2.9B
| $14.9M | 0.04% |
1,207,691
+376,006
| +45% | +$5.99M |
|
Similar funds
VanEck Associates's Q4 2022 Portfolio in Review
As of Q4 2022, VanEck Associates held 1,486 positions worth $38.7B, up 15% from $33.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
VanEck Associates's Q4 2022 filing shows 101 new, 869 increased, 411 reduced and 62 closed positions. Its largest new stake was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M. The largest sale was Gilead Sciences, an estimated $133M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, up from 34% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q4 2022 buy was NextEra Energy, Inc. 6.926% Corporate Units: 631,037 shares worth $31.7M.
- VanEck Associates added most to Newmont in Q4 2022, an estimated $130M increase.
- VanEck Associates's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $133M.
- VanEck Associates fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q4 2022, selling an estimated $29.4M.
- VanEck Associates's ten largest holdings make up 24% of its $38.7B portfolio in Q4 2022.
- VanEck Associates opened 101 new positions and closed 62 in Q4 2022.
- VanEck Associates's portfolio value rose 15% quarter-over-quarter to $38.7B.
Based on VanEck Associates's 13F filing for Q4 2022, filed 8 Feb 2023.